Research progress on Th17 and T regulatory cells and their cytokines in regulating atherosclerosis

Qiong Wang1, Yurong Wang1, Danyan Xu2

  • 1Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.

Insights

Immune cells like helper T17 (Th17) and regulatory T cells (Tregs) significantly impact atherosclerosis. Imbalances in Th17/Treg cells and their associated cytokines, such as IL-17, influence disease progression and plaque stability.

Area of Science:

  • Immunology
  • Cardiovascular Medicine
  • Inflammation Biology

Background:

  • Atherosclerosis, a primary cause of coronary heart disease, is characterized by chronic arterial wall inflammation.
  • Immune cells critically influence the inflammatory processes driving atherosclerosis progression and outcomes.

Purpose of the Study:

  • To review the mechanisms of CD4+ T cell subsets, specifically helper T17 (Th17) cells and regulatory T cells (Tregs), in regulating atherosclerosis.
  • To focus on the roles of interleukin-17 (IL-17), IL-10, and other cytokines in atherosclerosis and the factors affecting their influence.

Main Methods:

  • Literature review of immunological mechanisms in atherosclerosis.
  • Analysis of the interplay between Th17 cells, Tregs, and cytokine profiles.
  • Examination of factors modulating cytokine effects in the context of atherosclerosis.

Main Results:

  • Interleukin-17 (IL-17), secreted by Th17 cells, can promote atherosclerosis but may also stabilize plaques.
  • Regulatory T cells (Tregs) exhibit a protective role in atherosclerosis.
  • An imbalance between Th17 and Treg cells is significantly implicated in atherosclerosis pathogenesis.

Conclusions:

  • Immune responses are crucial regulators of atherosclerosis.
  • Understanding immune cell mechanisms offers potential therapeutic targets for atherosclerosis.
  • Further research is essential to fully elucidate these mechanisms and support clinical drug development.
Abstract

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.3K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
44
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
5.2K
Inflammation01:38

Inflammation

Overview
54.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
23
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
31